SEC Comment Letter for BARCLAYS (BCS) — Sep 11, 2012
BARCLAYS PLC
Date: Sept. 11, 2012 · CIK: 0000312069 · Accession: 0000000000-12-049433
AI Filing Summary & Sentiment
Show Raw Text
September 10, 2012 Via E -mail Chris Lucas Group Finance Director Barclays PLC Barclays Bank PLC 1 Churchill Place London E14 5HP, England Re: Barclays PLC Barclays Bank PLC Form s 20-F for Fiscal Year Ended December 31, 2011 Filed March 30, 2012 Form 6 -K Filed July 27, 2012 File Nos. 001 -09246 and 001 -10257 Dear Mr. Lucas: We have reviewed your filings and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure. Please respond to this letter within ten business days by amending your filings, by providing the requested information, or by advising us when you will provide the requested response. Where we have requested changes in future filings, please include a draft of your proposed disclosures that clearly identifies new or revised disclosures. If you do not believe our comments apply to your facts and circumstances or do not believ e an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your filings and the information you provide in response to these comments, including the draft of your proposed disclosures, we may have additional com ments. Form s 20-F for Fiscal Year Ended December 31, 2011 Board Corporate Governance and Nominations Committee Report, page 9 1. We note from your disclosure on page 10 that in 2011 you concluded that the Committee’s performance could be improved and tha t you implemented an action plan as a result. In future filings, please expand your disclosure to explain the action plan and how it changed Committee processes. Chris Lucas Barclays PLC Barclays Bank PLC September 10, 2012 Page 2 Board Audit Committee Chairman’s Report, page 12 Internal Controls, page 13 2. Please expand your disclosure in future filings to describe the material components of the remediation program that was implemented following the fine imposed on Barclays Capital for breaches of client asset segregation rules and your compliance with the program. 3. Pleas e describe your compliance with the undertakings contained in the Deferred Prosecution Agreement related to US sanctions and US dollar payment practices. Key Risk Issues, page 15 4. In future filings, please provide expanded disclosure that addresses the re solution of the key risk issues presented in this section. With respect to risks relating to your risk management framework, please also expand your disclosure in the “Risk management” section to explain the results of the Committee’s consideration of the se issues, including whether changes to risk management occurred as a result of such review. Risk Management, page 40 Credit Risk, page 52 F. Identifying Credit Risk Loans, page 62 5. Please revise your disclosure in future filings to describe how you det ermine the emergence period for purposes of determining the appropriate amount of allowance for loan losses. If this varies by loan type, please provide this disclosure by loan type. Additionally, to the extent that the emergence periods vary over time, please discuss the drivers that result in the shortening or lengthening of the emergence periods. I. Forbearance, page 64 6. We note your disclosure that you utilize a management overlay as the only practical means of factoring certain recent conditions into impairment calculations for your retail accounts until your models can be recalibrated. Please revise your disclosure in future filings to discuss the factors considered in determining the amount of overlay related to these loans and discuss the diff erences between this process and that used for your regular retail loan portfolio. Chris Lucas Barclays PLC Barclays Bank PLC September 10, 2012 Page 3 Retail Credit Risk, page 69 7. Please revise your disclosure in future filings to discuss the difference between accounting charge -off and write -off. For example, if the accounting charge -off relates to the valuation reserve, please clarify that. Please also disclose the impact that the shortened period between accounting charge -off and write -off has had on your provision and allowance for loan losses, and quantify the im pact where possible. In this regard, we note that the reduction of the period between accounting charge -off and write -off from 18 months to 12 months across the majority of the unsecured portfolios was, at least in part, disclosed as a factor driving the reduction in credit risk loans and potential credit risk loans, as well as reduction in impairment allowances. 8. We note your disclosure on page 73 that you would not consider a retail loan to be renegotiated where the amendment is at the request of the cus tomer, there is no evidence of actual or imminent financial difficulty and the amendment meets with all of your underwriting criteria. Given the nature of retail loans, clarify how often all of these conditions would be met at the time of the amendment an d discuss the types of situations driving the amendment. For example, clarify whether this situation typically occurs when the borrower chooses to refinance based on lower current market interest rates. 9. We note that your table on page 73 excludes certain interest -only UK home loans that have not been classified as forbearance because the monthly contractual cash flows have not been altered. Please respond to the following. Tell us how you concluded that these loans should not be classified as forbearanc e considering that the overall timing of contractual cash flows of the loans have been altered. Tell us whether the borrower initiated the forbearance request due to financial difficulty and clarify whether the term extensions were occurring at the end of the interest -only period or after amortization began. Clarify how term extensions on this loan product differ from term extensions on other UK home loans which do result in the classification as forbearance. Discuss whether you consider these loans as a separate risk pool when determining the appropriate amount of collective retail allowance for loan losses and tell us how you considered paragraphs AG87 -AG88 of IAS 39 in your conclusion. 10. We note your disclosure that you allow re -aging of an accoun t once in 12 months or twice in 5 years, providing strict qualification criteria are met, including making three consecutive monthly payments. You also disclose the fact that these re -aged accounts are Chris Lucas Barclays PLC Barclays Bank PLC September 10, 2012 Page 4 not considered to be restructured because the contrac tual monthly payments remain unchanged. Please respond to the following. Revise your disclosure in future filings to disclose the balance of re -aged loans for each period presented and discuss changes in and levels of re -aged loans. A tabular roll forwa rd may be helpful. Disclose how you considered the change in the timing of overall contractual payments when concluding that these loans should not be reported as renegotiated because the monthly payment amounts have not changed. Discuss the “strict qualification” criteria that must be me before you allow the re - aging to occur. Provide disclosure of the success rates of your re -aging criteria. For example, discuss the percentage of borrowers that receive a re -aging that later r equire another re -aging or forbearance program, or that later default on the loan. Tell us whether you consider these loans as a separate risk pool when determining the appropriate amount of collective retail allowance for loan losses and tell us how you considered the guidance in paragraphs AG 87 -88 of IAS 39 in your conclusion. Market Risk, page 94 Margin and Balances, page 99 11. We note that your presentation analyzing net interest income has been separated between customer interest income and non -custo mer interest income, which principally arises from your hedging activities. Please tell us and expand your disclosure in future filings to better explain how interest income is earned on customer assets and customer liabilities and the types of instrument s classified, and invested in, within each category. For example, clarify whether customer assets represents things such as loans and receivables classified as assets in your financial statements from which you recognize interest income, and customer liab ilities represent things such as deposits and repurchase agreements which are classified as liabilities in your financial statements, but where you invest the proceeds in other assets such as securities and interest income is earned. Net Interest Margin, page 100 12. We note your disclosure that your customer asset margin is determined by applying an internal funding rate to customer assets and liabilities. Please expand your disclosure in future filings to describe how your internal funding rate is determin ed for the purpose of Chris Lucas Barclays PLC Barclays Bank PLC September 10, 2012 Page 5 this disclosure. As part of your expanded disclosure, please consider disclosing the range of internal funding rates determined for each of the businesses, as well as the average internal funding rate which is used for purposes of th is disclosure. Please also discuss whether there have been any changes during the reported periods in the internal funding rate and if so quantify the impact such changes have had on your disclosure. Funding Risk – Liquidity, page 112 Liquidity Pool, p age 114 13. We note your tabular disclosure that you have £152 billion of assets in the liquidity pool, of which 94% is located at Barclays Bank PLC. Your disclosure also states that the “residual liquidity pool” is held predominantly within Barclays Capital Inc. (BCI) against contractual and contingent stress outflows in the Liquidity Risk Appetite stress test at the legal entity level. We also note your disclosure on page 158 that indicates that Barclays Capital has a liquidity pool of £152 billion, which appears to be the same liquidity pool. Please revise your future filings to quantify the amount of liquidity pool that is attributable to Barclays PLC, Barclays Bank PLC and at Barclays Capital to arrive at the total Group liquidity pool and clarify if th ere is any difference between the “liquidity pool” and the “residual liquidity pool.” Discuss whether there are any restrictions on any of the liquidity pools at any of these entities that may restrict the availability of liquidity other entities within t he Group and , if so, revise your disclosure to provide a brief discussion of those restrictions. Refer to Item 303(a)(1) of Regulation S -K. 14. In this regard, we also note your disclosure that the liquidity pool moved within a month end range of £140 billi on to £167 billion and that at June 30, 2012 you disclose on page 3 of your Form 6 -K filed July 27, 2012 that this range was £152 billion to £173 billion . Given the variance in the month end range amounts, please revise to provide an average balance of your liquidity pool during the period. Liquidity Regulation, page 116 15. We note your disclosures here and on page 36 of your Form 6 -K filed July 27, 2012 presenting the Liquidity Coverage Ratio (LCR) and the Net Stable Funding Ratio (NSFR). Given that these measures are based on Basel III, which has not yet been implemented, they appear to be non -GAAP measures as defined by Item 10(e) of Regulation S -K. P lease revise future filings to label the measure as non -GAAP and provide further clarifying disclosures regarding the use of the metrics, including more discussion on how they are calculated. Chris Lucas Barclays PLC Barclays Bank PLC September 10, 2012 Page 6 Consolidated Financial Statements, page 169 Consolidated Ca sh Flow Statement, page 173 16. We note the line item net decrease/(increase) in loans and advances to banks and customers shows a £38.3 billion decrease in loans and advances to banks and customers during the year ended December 31, 2011, but the consolidate d balance sheet shows a £13.6 billion increase in those two line items between December 31, 2010 and 2011. Please tell us the factors driving the differences between the loan balances between these two financial statements. Notes to the Financial Statements, page 176 7 – Credit Impairment Charges and Impairment on Available -for-Sale Assets, page 182 17. Please revise your future filings to disclose your policy for evaluating interest income for collectability. In this regard, we note your policy tha t following impairment, interest income continues to be recognized at the original effective interest rate on the restated carrying amount, in accordance with paragraph AG 93 of IAS 39, but you also have certain nonaccrual lendings , per your disclosure in footnote (a) to the average balance sheet table on page 280. As part of your response and expanded disclosure, please discuss the factors considered when placing loans on non -accrual and the factors considered when returning a loan to accrual status. 26 - Goodwill and Intangible Assets, page 214 Critical Accounting Estimates and Judgments, page 215 18. Please revise your disclosure in future filings to discuss how you determine the carrying value of your cash generating units for the purposes of determining goodwill impairment . Please address the following. Clarify in further detail whether you use a capital allocation methodology to determine the carrying value of your cash generating units. For example, tell us whether, and if so how, you con sider economic capital allocated to your cash generating units for this purpose. Specifically, discuss whether you allocate your shareholder’s equity to your cash generating units on a pro rata basis using assigned economic capital as a basis for allocati on or whether you simply use the economic capital assigned to the cash generating unit. To the extent the total capital required to support all of your cash generating units’ activities is more or less than the total shareholder’s equity of the Group, ple ase tell us how you account for any difference. In this regard, your disclosure on Chris Lucas Barclays PLC Barclays Bank PLC September 10, 2012 Page 7 page 108 indicates that you may not allocate all of your capital to your businesses when determining the amount of required economic capital. For example, we note the peri od end average economic capital requirement (including pension risk and excluding goodwill) is less than shareholders’ equity of the Group and shareholders’ equity excluding non -controlling interests less goodwill. Please clarify how any capital not alloc ated to the cash generating units is not considered when determining the fair value of the cash generating unit. To the extent that you do not utilize a capital allocation model to determine the carrying value of your cash generating units, please clarif y whether you allocate any recognized liabilities to your cash generating units for purposes of determining the carrying value of the cash generating units. Additional Financial Disclosure (Unaudited), page 277 Commitments and Contractual Obligations, pa ge 278 19. We note that your contractual obligations table appears to exclude the related interest expense on your long -term debt obligations which appears to be significant based on your supplemental cash flow information disclosure of cash paid for interest during each of the three years presented and your disclosure in Note 3. Please revise this table in future filings to include estimated interest payments on your long -term debt and disclose any assumptions you made to derive these amounts. To the extent that you can reasonably estimate the amount and/or timing of payments that you will be obligated to make under interest rate swaps or similar derivatives you use to manage interest rate risk related to your long -term debt, please ensure these amounts are i ncluded in the table and disc